- Home
- FUNC vs LYEL Comparison
FUNC vs LYEL Comparison
Compare FUNC & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUNC
- LYEL
- Stock Information
- Founded
- FUNC 1900
- LYEL 2018
- Country
- FUNC United States
- LYEL United States
- Employees
- FUNC N/A
- LYEL N/A
- Industry
- FUNC Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- FUNC Finance
- LYEL Health Care
- Exchange
- FUNC Nasdaq
- LYEL Nasdaq
- Market Cap
- FUNC N/A
- LYEL 207.7M
- IPO Year
- FUNC N/A
- LYEL 2021
- Fundamental
- Price
- FUNC $29.69
- LYEL $0.54
- Analyst Decision
- FUNC
- LYEL Sell
- Analyst Count
- FUNC 0
- LYEL 2
- Target Price
- FUNC N/A
- LYEL $1.00
- AVG Volume (30 Days)
- FUNC 17.6K
- LYEL 878.9K
- Earning Date
- FUNC 04-22-2025
- LYEL 03-11-2025
- Dividend Yield
- FUNC 2.94%
- LYEL N/A
- EPS Growth
- FUNC 40.00
- LYEL N/A
- EPS
- FUNC 3.15
- LYEL N/A
- Revenue
- FUNC $76,870,000.00
- LYEL $61,000.00
- Revenue This Year
- FUNC $13.86
- LYEL N/A
- Revenue Next Year
- FUNC $8.36
- LYEL N/A
- P/E Ratio
- FUNC $9.77
- LYEL N/A
- Revenue Growth
- FUNC 10.26
- LYEL N/A
- 52 Week Low
- FUNC $19.17
- LYEL $0.48
- 52 Week High
- FUNC $42.50
- LYEL $3.15
- Technical
- Relative Strength Index (RSI)
- FUNC 35.25
- LYEL 43.73
- Support Level
- FUNC $29.08
- LYEL $0.53
- Resistance Level
- FUNC $31.03
- LYEL $0.63
- Average True Range (ATR)
- FUNC 0.99
- LYEL 0.07
- MACD
- FUNC 0.06
- LYEL -0.00
- Stochastic Oscillator
- FUNC 21.63
- LYEL 25.19
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.